Multiple Myeloma
  • Featured content
    Carol Ann Huff, MD, discusses the clinical impact of the monoclonal antibody daratumumab for the treatment of patients with multiple myeloma, with practical insights for using this agent in your practice.
    Date Posted: 3/2/2018
  • Featured content
    Tune in to this on-demand Webcast in which Carol Ann Huff, MD, provides expert perspective on the optimal treatment of patients with myeloma, including discussion of recently approved agents and adverse event management.
  • Featured content
    Experts highlight key data to help you learn what to expect at the upcoming Hematology meeting in Atlanta. The CCO ASH Conference Coverage program will feature downloadable slides and expert analysis of these and dozens of other clinically relevant studies presented at ASH. We will have the information you need to understand and integrate the latest hematology data into your practice.
    Date Posted: 12/6/2017
  • Featured content
    In this archived Webcast from the 2017 CCO Multiple Myeloma Local Live meeting series, Raymond L. Comenzo, MD, provides expert perspective on integrating new agents and approaches into the treatment of patients with multiple myeloma.
  • Featured content
    David R. Gandara, MD; Daniel M. Geynisman, MD; Sara Hurvitz, MD, FACP; Elias Jabbour, MD; Shaji Kumar, MD; Brian Rini, MD, FACP; Tiffany A. Traina, MD; and Heather A. Wakelee, MD, each provide an analysis of key presentations on cancer immunotherapy from the 2016 clinical oncology meeting in Chicago.
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Content

10 of 294 Shown
10 of 294 Shown
Show 10 More
Loading...